Refractory Plasma Cell Neoplasm
3 clinical trials · Condition
◉ Watch Refractory Plasma Cell Neoplasm
| Record | Firm | Date |
|---|---|---|
| Vaccine Therapy in Treating Patients With Multiple Myeloma (NCT00019097) | National Cancer Institute (NCI) | 1995-07-01 |
| Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00085345) | Oncotherapeutics |
Track Refractory Plasma Cell Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.